Refined By:
Fulltext:  No Fulltext
Subject:  pharmacokinetics

Results 1-6 of 6 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)
11-Jan-2017Assessment of the pharmacokinetic profile of novel s-triazine derivatives and their potential use in treatment of Alzheimer's diseaseJovana Trifunović; Vladan Borčić; Saša Vukmirović ; Momir Mikov 
21-Jan-2009Cefotaxime pharmacokinetics after oral application in the form of 3α,7α-dihydroxy-12-keto-5β-cholanate microvesicles in ratSvetlana Goločorbin-Kon ; Momir Mikov ; Arafat M.; Žika Lepojević; Ivan Mikov ; Sahman-Zaimovic M.; Zdenko Tomić 
31-Mar-2016Do We Bury Antibacterials When Launching? Cefaclor ExampleZdenko Tomić ; Ana Tomas Petrović ; Saša Vukmirović ; Momir Mikov ; Olga Horvat ; Nataša Tomić ; Ana Sabo 
41-Jan-2008The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetesMomir Mikov ; Hani Al-Salami; Svetlana Goločorbin-Kon ; Ranko Škrbić; Aleksandar Rašković ; Paul J. Fawcett
51-Apr-2009Lamotrigine and valproate pharmacokinetics interactions in epileptic patientsMladena Lalić-Popović ; Jelena Helen Hogervorst ; Jovan Popović; Ksenija Božić; Svetlana Goločorbin-Kon ; Hani Al-Salami; Momir Mikov 
61-Oct-2017Structural insights into anticancer activity of D-ring modified estrone derivatives using their lipophilicity in estimation of SAR and molecular docking studiesJovana Trifunović; Vladan Borčić; Saša Vukmirović ; Momir Mikov